3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Pancreatic Neoplasms
3
Nasopharyngeal Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Neoplasm Metastasis
2
Meningioma
2
Liver Neoplasms
2
HER2-positive Breast Cancer
2
Glioma
2
Glioblastoma
2
Chordoma
2
Carcinoma, Hepatocellular
2
Carcinoma, Adenoid Cystic
2
Brain Neoplasms
2
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Radiation Injuries
1
Pituitary Neoplasms
1
Oligodendroglioma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Interventions
Doxorubicin
69
Radiotherapy
50
Ifosfamide
48
Gemcitabine
43
Cyclophosphamide
36
pazopanib
29
Filgrastim
28
pembrolizumab
26
Docetaxel
26
Nivolumab
23
Etoposide
21
Cisplatin
21
Surgical Procedures, Operative
20
Trabectedin
19
Blood Specimen Collection
19
Carboplatin
15
Radiation
14
Magnetic Resonance Spectroscopy
14
Vincristine
13
Bevacizumab
13
Temozolomide
12
Peripheral Blood Stem Cell Transplantation
12
Ipilimumab
12
liposomal doxorubicin
11
apatinib
11
anlotinib
11
Radiosurgery
11
Melphalan
11
Surveys and Questionnaires
10
Sirolimus
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma
×
Protons
×
Clear all
NCT04946357
2026-04-06
EXTREM ION
University Hospital Heidelberg
Phase NA
Recruiting
42 enrolled
NCT02838602
2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA
Recruiting
250 enrolled